Chimerix reported 23.89M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Chimerix CMRX:US 23.89M 899K
Curis CRIS:US $ 17.45M 264K
Dynavax Technologies DVAX:US $ 128.24M 45.01M
Emergent Biosolutions EBS:US $ 314.7M 13.6M
Epizyme EPZM:US $ 57.33M 2.29M
Gilead Sciences GILD:US $ 4231M 2162M
Glaxosmithkline GSK:US 5.85B 1.13B
Life Technologies LIFE:US $ 12.38M 3.74M
Merk MRK:US $ 9666M 666M
Mirati Therapeutics MRTX:US $ 182.57M 2.36M
Novavax NVAX:US $ 668.88M 174.21M
Xoma XOMA:US $ 5.75M 578K